The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: A new version of the UVA/Padova Type 1 Diabetes (T1D) Simulator is presented which provides a more realistic testing scenario. The upgrades to the previous simulator, which was accepted by the Food and Drug Administration in 2013, are described. Method: Intraday variability of insulin sensitivity (S I ) has been modeled, based on clinical T1D data, accounting for both intra- and intersubject variability of daily S I . Thus, time-varying distributions of both subject’s basal insulin infusion and insulin-to-carbohydrate ratio were calculated and made available to the user. A model of “dawn” phenomenon based on clinical T1D data has been also included. Moreover, the model of subcutaneous insulin delivery has been updated with a recently developed model of commercially available fast-acting insulin analogs. Models of both intradermal and inhaled insulin pharmacokinetics have been included. Finally, new models of error affecting continuous glucose monitoring and self-monitoring of blood glucose devices have been added. Results: One hundred in silico adults, adolescent, and children have been generated according to the above modifications. The new simulator reproduces the intraday glucose variability observed in clinical data, also describing the nocturnal glucose increase, and the simulated insulin profiles reflect real life data. Conclusions: The new modifications introduced in the T1D simulator allow to extend its domain of validity from “single-meal” to “single-day” scenarios, thus enabling a more realistic framework for in silico testing of advanced diabetes technologies including glucose sensors, new insulin molecules and artificial pancreas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the simulation environment was extended beyond its initial single-meal realm of application; 73”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [73]
In the citing paper
“The inter-and intra-day insulin sensitivity variability of the FDA-accepted population 73 was retained.”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [73]
In the citing paper
“The FDA-accepted UVA/Padova T1D simulator for SC insulin delivery and sensing 73 has been updated for IP insulin delivery and IP glucose sensing.”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [73]
In the citing paper
“On the contrary, the Hovorka model and the UVAPadova model were originally formulated to represent the physiological behaviour of T1DM individuals, and no modification is necessary for the purpose of the present work.”
From A comparison among three maximal mathematical models of the glucose-insulin system (2021) · cites this paper as [24]
In the citing paper
“This model is indeed included in the EGP module of the UVa/Padova T1D simulator [32–34].”
From Modeling the effect of glucagon on endogenous glucose production in healthy individuals under meal-like conditions (2025) · cites this paper as [34]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Self-citationThe UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791 · cited 2×
“The pulmonary route of administration is described using the model of inhaled insulin pharmacokinetic described in Visentin et al.(34) This model (equations A20, A21) has been identified on 12 T1D subjects, and assumes that a certain fraction of inhaled insulin reaches the alveoli, and then it is rapidly absorbed from…”
MethodSelf-citationIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760 · cited 1×
“In particular, in 2008 the US Food and Drug Administration (FDA) accepted the T1D simulator developed by Universities of Virginia (UVA) and Padova as a substitute for preclinical trials for certain insulin treatments, including closed-loop algorithms for artificial pancreas (AP).(2) This dramatically accelerated the A…”
BackgroundSelf-citationDiabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
Self-citationEffects of Age and Sex on Postprandial Glucose Metabolism
Basu, R., Dalla Man, C., Campioni, M., Basu, A., Klee, G., Toffolo, G., Cobelli, C., & Rizza, R. A. (2006) · Diabetes · doi:10.2337/db05-1692 · Cited by 334
Self-citationSimulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Wilinska, M. E., Chassin, L. J., Acerini, C. L., Allen, J. M., Dunger, D. B., & Hovorka, R. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400117 · Cited by 244
Kropff, J., Del Favero, S., Place, J., Toffanin, C., Visentin, R., Monaro, M., Messori, M., Di Palma, F., Lanzola, G., Farret, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00335-6 · Cited by 201
Self-citationDavidson, P. C., Hebblewhite, H. R., Steed, R. D., & Bode, B. W. (2008) · Endocrine Practice · doi:10.4158/ep.14.9.1095 · Cited by 167 · cited 1×
“Total daily insulin (TDI) is determined from basal infusion rate and optimal CR, assuming an average diet of 180 g of CHO for adults and adolescents, and 135 g for children; correction factor (CF) is then calculated using the so-called 1700 rule.(39) Following Dalla Man et al,(7) some additional criteria have been con…”
MethodKanderian, S. S., Weinzimer, S., Voskanyan, G., & Steil, G. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300508 · Cited by 161 · cited 1×
“The ability to well reproduce diurnal variability is thus of interest, and other research groups have worked on this topic.(4,23-25) We recently demonstrated the ability of the T1D simulator model to describe glucose dynamics in a large dataset of T1D subjects studied for about 24 hours, by describing insulin sensitiv…”
Pinsker, J. E., Lee, J. B., Dassau, E., Seborg, D. E., Bradley, P. K., Gondhalekar, R., Bevier, W. C., Huyett, L., Zisser, H. C., & Doyle, F. J. (2016) · Diabetes Care · doi:10.2337/dc15-2344 · Cited by 151
Wang, Y., Dassau, E., & Doyle, F. J. (2010) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2009.2024409 · Cited by 150
Kovatchev, B., Cheng, P., Anderson, S. M., Pinsker, J. E., Boscari, F., Buckingham, B. A., Doyle, F. J., Hood, K. K., Brown, S. A., Breton, M. D., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0333 · Cited by 141
Self-citationDiurnal Pattern of Insulin Action in Type 1 Diabetes
Hinshaw, L., Dalla Man, C., Nandy, D. K., Saad, A., Bharucha, A. E., Levine, J. A., Rizza, R. A., Basu, R., Carter, R. E., Cobelli, C., et al. (2013) · Diabetes · doi:10.2337/db12-1759 · Cited by 125 · cited 2×
“In silico CR values at breakfast are lower than those at lunch and dinner within each cohort, in agreement with Hinshaw et al.27 The distributions of CR at breakfast, lunch, and dinner, together with that of CF in the three populations are also shown in Figure 3.”
ResultSelf-citationRun-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus
Owens, C., Zisser, H., Jovanovic, L., Srinivasan, B., Bonvin, D., & Doyle, F. J. (2006) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.872818 · Cited by 122
Multinational Home Use of Closed-Loop Control Is Safe and Effective
Anderson, S. M., Raghinaru, D., Pinsker, J. E., Boscari, F., Renard, E., Buckingham, B. A., Nimri, R., Doyle, F. J., Brown, S. A., Keith-Hynes, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2468 · Cited by 120
Self-citationCircadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R., Dalla Man, C., Kudva, Y. C., Basu, A., & Cobelli, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0192 · Cited by 113
Self-citationVettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2746340 · Cited by 111
Self-citationToward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results
Toffanin, C., Visentin, R., Messori, M., Palma, F. D., Magni, L., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2652062 · Cited by 107
Self-citationRun-to-Run Tuning of Model Predictive Control for Type 1 Diabetes Subjects: In Silico Trial
Magni, L., Forgione, M., Toffanin, C., Dalla Man, C., Kovatchev, B., De Nicolao, G., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300512 · Cited by 106
Self-citationRenard, E., Farret, A., Kropff, J., Bruttomesso, D., Messori, M., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0008 · Cited by 104
Self-citationVisentin, R., Dalla Man, C., Kovatchev, B., & Cobelli, C. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0377 · Cited by 103
Self-citationPerriello, G., Feo, P. D., Torlone, E., Fanelli, C. G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1991) · Diabetologia · doi:10.1007/bf00404020 · Cited by 89 · cited 1×
“subjects during early morning, due to both an increased endogenous glucose production (EGP) and an increased insulin requirements.(29,30) Recently, Mallad et al(29) quantified an almost 30 mg/dL increase in glucose concentration from 3:00 am to 7:00 am and observed an increase of EGP of about 1.”
BackgroundVisentin, R., Man, C. D., & Cobelli, C. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2535241 · Cited by 86 · cited 2×
“On the contrary, recent works demonstrated that simulation models need for a certain number of time-varying parameters in order to properly describe glucose metabolism during the day.(26,40) Therefore, we developed a model of SI intraday variability and a description of dawn phenomenon, thanks to available data on diu…”
BackgroundSelf-citationFacchinetti, A., Del Favero, S., Sparacino, G., & Cobelli, C. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-014-1226-y · Cited by 80
Self-citationDassau, E., Brown, S. A., Basu, A., Pinsker, J. E., Kudva, Y. C., Gondhalekar, R., Patek, S., Lv, D., Schiavon, M., Lee, J. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2081 · Cited by 74
Self-citationReddy, M., Pesl, P., Xenou, M., Toumazou, C., Johnston, D., Georgiou, P., Herrero, P., & Oliver, N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0413 · Cited by 70
Haidar, A., Wilinska, M. E., Graveston, J. A., & Hovorka, R. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2272736 · Cited by 69
Herrero, P., Bondia, J., Adewuyi, O., Pesl, P., El-Sharkawy, M., Reddy, M., Toumazou, C., Oliver, N., & Georgiou, P. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.05.010 · Cited by 63
Messori, M., Kropff, J., Del Favero, S., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., Lanzola, G., Farret, A., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0463 · Cited by 59
Self-citationForlenza, G. P., Deshpande, S., Ly, T. T., Howsmon, D. P., Cameron, F., Baysal, N., Mauritzen, E., Marcal, T., Towers, L., Bequette, B. W., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0500 · Cited by 58
Modeling Subcutaneous Absorption of Fast-Acting Insulin in Type 1 Diabetes
Schiavon, M., Dalla Man, C., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2784101 · Cited by 54
Self-citationHerrero, P., Pesl, P., Bondia, J., Reddy, M., Oliver, N., Georgiou, P., & Toumazou, C. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.02.003 · Cited by 43
Visentin, R., Giegerich, C., Jäger, R., Dahmen, R., Boss, A., Grant, M., Dalla Man, C., Cobelli, C., & Klabunde, T. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0128 · Cited by 36
Self-citationBrown, S. A., Breton, M. D., Anderson, S. M., Kollar, L., Keith-Hynes, P., Levy, C. J., Lam, D. W., Levister, C., Baysal, N., Kudva, Y. C., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00556 · Cited by 30
Self-citationHinshaw, L., Mallad, A., Dalla Man, C., Basu, R., Cobelli, C., Carter, R. E., Kudva, Y. C., & Basu, A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00236.2015 · Cited by 28
Self-citationMallad, A., Hinshaw, L., Man, C. D., Cobelli, C., Basu, R., Lingineni, R. K., Carter, R. E., Kudva, Y. C., & Basu, A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0011 · Cited by 26 · cited 3×
“Intersubject variability of both time interval and magnitude of kp1 increase and kir decrease are obtained as random modulation of the averages reported in Mallad et al.(29)”
BackgroundMethodSelf-citationClinical impact of blood glucose monitoring accuracy: an in-silico study
Campos-Náñez, E., Fortwaengler, K., & Breton, M. D. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817710474 · Cited by 22
Self-citationA Model of Self-Monitoring Blood Glucose Measurement Error
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817698498 · Cited by 21
Self-citationLv, D., Kulkarni, S. D., Chan, A., Keith, S., Pettis, R. J., Kovatchev, B. P., Farhy, L. S., & Breton, M. D. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815573864 · Cited by 12 · cited 1×
“The model of intradermal insulin route is based on Lv et al.(33) This model (equations A18, A19) has been identified on 10 healthy subjects, and assumes that insulin delivered at the intradermal site is then transported to the bloodstream via two independent routes, that is, a diffusion-like process and a combination…”
MethodSelf-citation
Research works printed but not linked: 3
- 10.1109/tbme.2013.2272736 · DOI · Paper page
- Schiavon M, 2016, Diabetologia, 59, s268
- Schiavon M, 2017, Diabetes Technol Ther, 19, A118
Cited by
Zou, Y., Chu, Z., Guo, J., Liu, S., Ma, X., & Guo, J. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115103 · Cited by 131
Chinese diabetes datasets for data-driven machine learning
Zhao, Q., Zhu, J., Shen, X., Lin, C., Zhang, Y., Liang, Y., Cao, B., Li, J., Liu, X., Rao, W., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-01940-7 · Cited by 129
Deep Reinforcement Learning for Closed-Loop Blood Glucose ControlPreprint
Fox, I., Lee, J. M., Pop‐Busui, R., & Wiens, J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2009.09051 · Cited by 118
“In our environment, this did not reduce performance relative to a longer input history, but this could be important for managing blood glucose levels in more realistic simulators or real-world cases Visentin et al. (2018).”
BackgroundLee, S., Kim, J., Park, S. W., Jin, S., & Park, S. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3002022 · Cited by 108
“[40] The variation of dawn phenomenon was determined with the same probability as the clinical observations reported in previous studies [41], [42].”
ResultMari, A., Tura, A., Grespan, E., & Bizzotto, R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.575789 · Cited by 80
Metadata
- Authors
- Visentin, R., Campos-Náñez, E., Schiavon, M., Lv, D., Vettoretti, M., Breton, M., Kovatchev, B. P., Dalla Man, C., & Cobelli, C.
- Affiliations
- University of Padua (IT)
- University of Virginia (US)
- Department of Information Engineering, University of Padova, Padova, Italy
- ORCID
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2018-02-16
- Volume
- 12
- Issue
- 2
- Pages
- 273-281
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC5851236
- OpenAlex
- W2790915589
- Semantic Scholar
- 55662e5d64d6d59abe32634a0272c0c17b04c13a
- Cited by
- 280
- References
- 39
- Citations by year
- 2026: 21 · 2025: 43 · 2024: 39 · 2023: 45 · 2022: 36 · 2021: 34 · 2020: 32 · 2019: 22 · 2018: 8
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, in silico modeling, insulin-to-carbohydrate ratio, dawn phenomenon, subcutaneous insulin administration, inhaled insulin, self-monitoring of blood glucose, artificial pancreas, glucose sensor
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Computer Simulation, Diabetes Mellitus, Type 1, Humans, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.